Impact Biomedical closes IPO of 1.5M shares at $3.00, net proceeds ~$3.76M

IMPACT BIOMEDICAL INC.

IPO of 1,500,000 common shares at $3.00 per share; net proceeds to company ~$3,764,500 after discounts and expenses.
Shares began trading on NYSE American on Sept 16, 2024 under ticker IBO; offering closed Sept 17, 2024.
Underwriters granted 45-day option to buy up to 225,000 additional shares at IPO price less discount.
Representative's warrants issued for 75,000 shares (5% of offering) at $3.75/share, exercisable from 9 months to 3 years.
Company and insiders subject to 6-month lock-up on share sales after effective date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.